The prevalence of antibody to human parvovirus B19 in pregnant women in Kuwait

Acta Tropica

Volumn 73, Issue 3, 1999, Pages 225-229

  Maksheed, Ma'Asoumah ^a   Pacsa, A S ^a   Essa, Sahar Sultan ^a   Ahmed, Mohammad Abrar ^a   Monem, Rawiya Abdul ^a   Surkouh, Mansour ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b Salmiya Polyclinic   (Kuwait)

Author keywords

Kuwait; Parvovirus B19; Pregnant women

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

HEALTH STATUS; MATERNAL HEALTH; WOMENS HEALTH;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; APLASTIC ANEMIA; ARTICLE; BLOOD SAMPLING; FEMALE; FETUS; FETUS HYDROPS; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; PARVOVIRUS; PREGNANCY COMPLICATION; RACE DIFFERENCE; SEROPREVALENCE; VIRUS INFECTION;

ADULT; ANTIBODIES, VIRAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KUWAIT; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES;

KUWAIT;

HYDROPS; PARVOVIRUS;

EID: 0032730450     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(99)00033-9     Document Type: Article

References (21)

1. Anand A., Gray E.S., Brown T., Clewley J.P., Cohen B.J. Human parvovirus infection in pregnancy and hydrops fetalis. New Engl. J. Med. 316:1987;184-186.
2. Bruu A.L., Nordbo S.A. Evaluation of five commercial tests for detection of immunoglobulin M antibodies to human parvovirus B19. J. Clin. Microbiol. 33:1995;1363-1365.
3. Carrington D., Gilmore D.H., Whittle M.J. et al. Maternal serum alpha fetoprotein: a marker of fetal aplastic crisis during intrauterine human parvovirus infection. Lancet. i:1984;433-435.
4. Caul E.O., Usher J.M., Burton A.P. Intrauterine infection with human parvovirus B19: a light and electron microscopy study. J. Med. Virol. 24:1988;55-66.
5. Cohen B.J. Parvovirus B19: an expanding spectrum of disease. Br. Med. J. 311:1995;1549-1552.
6. Cohen B.J., Bukley M.M. The prevalence of antibody to human parvovirus B 19 in England and Wales. J. Med. Mircrobiol. 25:1988;151-153.
7. Cohen B.J., Mortimer P.P., Pereira M.S. Diagnostic assays with monoclonal antibodies for the human-serum parvovirus like virus (SPLV). J. Hyg. (London). 91:1983;113-130.
8. Cossart Y.E., Field A.M., Cant B., Widdows D. Parvovirus like particles in human sera. Lancet. i:1975;72-73.
9. De Freitas R.B., Wong D., Boswell F. et al. Prevalence of human parvovirus (B19) and rubella virus infections in urban and remote rural areas in northern Brazil. J. Med. Virol. 32:1990;203-208.
10. Gratacos E. et al. The incidence of human Parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J. Infect. Dis. 171:1995;1360-1363.
11. Kinney J.S., Anderson L.J., Farrar J. et al. Risk of adverse outcomes of pregnancy after human parvovirus B19 infection. J. Infect. Dis. 157:1998;663-667.
12. Koch W.C., Adler S.P. Human parvovirus B19 infections in women of childbearing age and within families. Pediatr. Infect. Dis. J. 8:1989;83-87.
13. Miller E., Fairley C.K., Cohen B.J., Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br. J. Obstet. Gynaecol. 105:1998;174-178.
14. Mortimer P.P., Luban N.L.C., Kelleher J.F., Cohen B.J. Transmission of serum parvovirus like virus by clotting-factor concentrates. Lancet. ii:1983;482-484.
15. Nascimento J.P., Buckly M.M., Brown K.E., Cohen B.J. The prevalence of antibody to human parvovirus B19 in Rio de Janeiro, Brazil. Rev. Inst. Med. Trop. Sao Paulo. 32:1990;41-45.
16. Nunoue T., Okochi K., Mortimer P.P., Cohen B.J. Human parvovirus (B19) and erythema infectiosum. J. Pediatr. 107:1985;38-40.
17. Schwarz T.F., Gurtler L.G., Zoulek G., Deinhardt F., Roggendorf M. Seroprevalence of human parvovirus B19 infection in Sao Tome and principe, Malawi and Mascarene Islands. Int. J. Med. Microbiol. 271:1989;231-236.
18. Shmoys S., Kaplan C. Parvovirus and pregnancy. Clin. Obstet. Gynecol. 33(2):1990;265-275.
19. Sparre L.S., Fridell E., Nyman M., Wahren B. A prospective study of antibodies against parvovirus B19 in pregnancy. Acta Obstet. Gynecol. Scand. 75:1996;336-339.
20. Woernle C.H., Anderson L.J., Tattersall P., Davison J.M. Human parvovirus B19 infection during pregnancy. J. Infect. Dis. 156:1987;17-20.
21. Yaegashi N., Okamura K., Hamazaki Y., Yajima A., Shiraishi H., Sugamura K. Prevalence af anti-human parvovirus antibody in pregnant women. Nippon Sanka Fujinka Gakkai Zasshi. 42(2):1999;162-166.